Family Medicine · San Gabriel, CA
NPI
1366483497
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
140 W Valley Blvd, Suite 220
San Gabriel, CA, 91776
Phone (626) 307-0797
Groups this clinician bills Medicare through
Medicare paid, 2024
$186K
4,834 services
Medicare patients, 2024
354
Average age 78
Drug cost, 2024
$2.8M
22,757 prescriptions
Company payments, 2025
$2,281
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hsiao- Fen Chen was code 99213 (office e&m - established), 1,451 times for 302 patients. In total Hsiao- Fen Chen billed 4,834 services in 33 codes, and Medicare paid $186K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-01-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 1,451 | 302 | $60.56 | $88K |
| 96372 Injection Administration | Office | 667 | 138 | $10.31 | $6,878 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 506 | 96 | $0.80 | $404 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 386 | 187 | $11.75 | $4,535 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 275 | 275 | $20.30 | $5,583 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 271 | 271 | $135.03 | $37K |
| 93000 Electrocardiogram | Office | 260 | 248 | $9.85 | $2,562 |
| 99214 Office E&M - Established | Office | 216 | 156 | $90.22 | $19K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 161 | 32 | $0.61 | $98.17 |
| G0008 Administration of influenza virus vaccine | Office | 149 | 146 | $35.02 | $5,218 |
| 90656 Vaccine Product | Office | 112 | 110 | $21.90 | $2,453 |
| 99442 Telephone Services | Office | 70 | 30 | $58.02 | $4,062 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 55 | 12 | $0.32 | $17.43 |
| J0897 Injection, denosumab, 1 mg | Office | 52 | 46 | $0.01 | $0.39 |
| 90661 Vaccine Product | Office | 28 | 28 | $36.11 | $1,011 |
By year: 2022 $207K for 5,015 services; 2023 $167K for 4,557 services; 2024 $186K for 4,834 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 13 | 13 | $4.90 | $63.7 |
Medicare prescription drug claims, 2024
In 2024, the drug Hsiao- Fen Chen prescribed most often to Medicare patients was Amlodipine Besylate, with 1,481 prescriptions and refills. In total Hsiao- Fen Chen wrote 22,757 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 1,481 | 3,071 | 313 | $7,733 |
| Azithromycin Generic | 948 | 948 | 343 | $2,682 |
| Atorvastatin Calcium Generic | 913 | 2,016 | 198 | $7,759 |
| Levocetirizine Dihydrochloride Generic | 841 | 1,239 | 207 | $6,562 |
| Montelukast Sodium Generic | 774 | 1,048 | 183 | $4,436 |
| Losartan Potassium Generic | 764 | 1,673 | 152 | $7,886 |
| Raloxifene Hcl Generic | 608 | 1,333 | 135 | $25K |
| Olmesartan Medoxomil Generic | 571 | 1,108 | 126 | $7,857 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 528 | 538 | 139 | $22K |
| Meloxicam Generic | 441 | 598 | 122 | $1,150 |
| Vascepa Icosapent Ethyl | 428 | 584 | 80 | $193K |
| Mupirocin Generic | 426 | 433 | 109 | $2,504 |
| Rosuvastatin Calcium Generic | 424 | 994 | 103 | $5,210 |
| Triamcinolone Acetonide Generic | 396 | 423 | 93 | $6,672 |
| Fluticasone Propionate Generic | 360 | 422 | 76 | $3,155 |
Brand drugs: 3,852 claims; generic drugs: 18,861 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hsiao- Fen Chen $2,281 ($2,281 in general payments such as food, travel and fees) from 20 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $806.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 13 | $806 |
| GlaxoSmithKline, LLC. GSK | 7 | $326 |
| Amgen Inc. AMGN | 20 | $249 |
| Abbvie Inc. ABBV | 10 | $176 |
| Vivus LLC | 1 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 4 | $99.69 |
| Pfizer Inc. PFE | 4 | $94.15 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $65.12 |
| Exact Sciences Corporation EXAS | 2 | $49.93 |
| Kowa Pharmaceuticals America, Inc. | 2 | $43.15 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.